Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Glioblastoma 17Gliosarcoma 15Central Nervous System Neoplasms 14Astrocytoma 13Brain Neoplasms 10Glioma 8Oligodendroglioma 7Unspecified Adult Solid Tumor, Protocol Specific 3Optic Nerve Glioma 3Medulloblastoma 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Non-Hodgkin 3Familial ependymoma 3Choroid Plexus Neoplasms 3Sezary Syndrome 2Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Mycosis Fungoides 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hodgkin Disease 2Ependymoma 2Burkitt Lymphoma 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Testicular Neoplasms 1

Interventions

Dexamethasone 809Bortezomib 449Lenalidomide 430Cyclophosphamide 336Melphalan 251Calcium Dobesilate 237daratumumab 218pomalidomide 202carfilzomib 181fludarabine phosphate 131Thalidomide 121fludarabine 118Peripheral Blood Stem Cell Transplantation 117Filgrastim 111ixazomib 85Mycophenolic Acid 85Granulocyte Colony-Stimulating Factor 84Busulfan 83Whole-Body Irradiation 80Tacrolimus 75dexamethasone acetate 74Cyclosporine 67isatuximab 64Prednisone 64dexamethasone 21-phosphate 63elotuzumab 60auricularum 57belantamab mafodotin 55Antilymphocyte Serum 55Etoposide 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multiple Myeloma × O(6)-benzylguanine × Clear all
NCT00004072 2010-06-11

O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma

Case Comprehensive Cancer Center

Phase 2 Completed
17 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡